Positive News Coverage Somewhat Unlikely to Affect Alere (ALR) Share Price

News headlines about Alere (NYSE:ALR) have been trending positive this week, Accern reports. The research group identifies positive and negative media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Alere earned a news impact score of 0.26 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 45.4631683424545 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

A number of research firms have commented on ALR. BidaskClub upgraded shares of Alere from a “sell” rating to a “hold” rating in a research note on Thursday, August 17th. Canaccord Genuity restated a “hold” rating and set a $51.00 target price on shares of Alere in a research note on Tuesday, September 19th. Finally, Zacks Investment Research cut shares of Alere from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $51.00.

Alere (NYSE ALR) remained flat at $$50.99 during midday trading on Friday. The company had a trading volume of 1,218,600 shares, compared to its average volume of 1,525,780. Alere has a 1 year low of $34.41 and a 1 year high of $51.00. The company has a current ratio of 2.04, a quick ratio of 1.54 and a debt-to-equity ratio of 2.43.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.thestockobserver.com/2017/11/24/positive-news-coverage-somewhat-unlikely-to-affect-alere-alr-share-price.html.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Insider Buying and Selling by Quarter for Alere (NYSE:ALR)

Receive News & Ratings for Alere Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply